Wednesday, February 27, 2019

This Is the Best Way to Fix Social Security, New Analysis Shows

This may come as little shock to many of you, but Social Security is in some pretty big trouble. Since 1985, the annually released Board of Trustees report has estimated that the program had insufficient revenue generation to cover beneficiary payouts, inclusive of cost-of-living adjustments (COLA), over the long run, which is defined as the next 75 years.

Due to a number of ongoing demographic changes, such as the retirement of baby boomers from the workforce, the long-term lengthening of life expectancies, growing income inequality, and more recently, persistent declines in fertility rates, there simply won't be enough revenue coming into the program to sustain the current payout schedule. The Social Security Board of Trustees has forecast that the program's nearly $2.9 trillion in asset reserves will be depleted by 2034 as a result of net cash outflows from the program (set to begin soon), with an across-the-board benefits cut to follow of up to 21%.

Dice and casino chips lying atop two Social Security cards.

Image source: Getty Images.

Social Security's problems may be worse than you realize

But what you may not realize is that some analysts view Social Security's situation to be even direr than what the Trustees report has presented.

This past August, The Penn Wharton Budget Model (PWBM), a nonpartisan, research-based initiative that analyzes the fiscal impacts of public policy, found the Social Security program to be on far worse footing than initially projected. According to PWBM, the nation's growing debt is expected to "erode the size of the future tax base," which will further compromise cash flow into the program.

With this in mind, PWBM ran an analysis that incorporated a number of future macroeconomic variables, including growing national debt levels, and found a 36% larger cash shortfall by 2032 compared to the Trustees' report, and a 77% larger projected cash flow shortfall by 2048 relative to the Trustees' model. Furthermore, the PWBM model forecasts that national debt-to-GDP ratio will top 200% by 2048, which wouldn't be sustainable for very long. 

Regardless of which model you prefer to follow, they both agree that Social Security's current income stream won't be sufficient to maintain the existing payout schedule for too much longer without (1) additional revenue, (2) expenditure cuts, or (3) some combination of the above two measures. Though this seems pretty simple and straightforward, finding a resolution to Social Security's cash shortfall has been anything but easy.

Two Social Security cards lying atop fanned piles of cash bills.

Image source: Getty Images.

There are no shortage of options to tackle Social Security's cash flow issues

Arguably the biggest issue is figuring out how best to tackle the problem. In other words, analysts understand the solutions available, but there's little consensus or understanding on how those options would impact the program and/or economy over the long run. Thanks to a newly released analysis from PWBM, we now have that answer.

Earlier this month, the PWBM released its newest analysis on Social Security's long-term outlook (defined as a 30-year forward-looking model, through 2048) by examining how six options to "fix" Social Security's cash shortfall would hold up against its current path, which the Trustees opine is $13.2 trillion short of cash between 2034 and 2092.

The PWBM analysis to resolve Social Security's cash shortfall tinkered with six variables -- three from the tax side of the equation and three from the benefit side of the aisle. In terms of tax implications, it looked at adjustments to the 12.4% payroll tax rate on earned income, the maximum taxable earnings cap, and introducing a payroll tax on high income earnings above a certain "donut-hole" figure, which in this instance was $250,000. As for benefit provisions, it examined changes to how COLA is measured, made adjustments to the primary insurance amount, and analyzed changes to the full retirement age. You can see all of these options in Table 1 of the PWBM analysis.

Three seniors holding notebooks and clipboards while standing together

Image source: Getty Images.

This is the best way to fix Social Security

So, which combination of policy changes worked out best? Interestingly, all six options improved GDP growth over the long run more than the current model. But in terms of long-term GDP growth, Option E proved to be the best. Here's what Option E entails:

Increases the payroll tax rate to 13.6% (currently 12.4%) Lifts the payroll tax earnings tax cap to $150,000 (currently $132,900) Does not institute a tax on the well-to-do earning $250,000 or more a year Adjusts the program's inflationary measure from the CPI-W to the Chained CPI Lowers the Primary Insurance Amount from 90/30/15 to 90/25/8 Increases the full retirement age to 70 (currently set to peak at 67 for those born in 1960 or later)

What stands out about this optimal fix? Well, don't fall over, but it's bipartisan. What PWBM found out was that tax revenue increases and benefit reduction were both needed to help offset issues that Social Security is contending with.

For example, the model notes that tax revenue increases, such as lifting the earnings tax cap, creates an immediate increase in revenue. However, it also points out that the donut-hole tax, which wasn't included in the "best" option, tends to reduce labor supply and coerce the rich to get creative with their income generation. PWBM notes that some well-to-do persons may defer income realization or derive their income from small businesses to avoid a higher tax rate. In short, raising taxes works quickly to address the cash flow shortfall, but it tends to produce lower long-term economic growth.

Meanwhile, PWBM's newest analysis finds that benefit reductions often move slowly when it comes to addressing the program's cash shortfall, but they do have a positive impact of requiring households to save more for their own retirement. Opposite to tax increases, benefit cuts tend to provide the highest long-term GDP growth.

In other words, the best way to fix Social Security is going to be with a balanced approach that incorporates an increase in taxable revenue, as called for by Democrats, as well as a reduction in long-term benefits, as proposed by Republicans.

Tuesday, February 26, 2019

Top 5 Casino Stocks To Invest In 2019

tags:HIVE,GRC,VLGEA,ONCS,FARM,

Zurich Insurance Group Ltd FI increased its stake in shares of Las Vegas Sands Corp. (NYSE:LVS) by 14.8% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 80,741 shares of the casino operator’s stock after acquiring an additional 10,389 shares during the quarter. Zurich Insurance Group Ltd FI’s holdings in Las Vegas Sands were worth $6,165,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Point72 Asia Hong Kong Ltd bought a new position in shares of Las Vegas Sands during the first quarter worth $118,000. Flagship Harbor Advisors LLC bought a new position in shares of Las Vegas Sands during the second quarter worth $135,000. Synovus Financial Corp bought a new position in shares of Las Vegas Sands during the first quarter worth $152,000. Zacks Investment Management bought a new position in shares of Las Vegas Sands during the second quarter worth $202,000. Finally, Pennsylvania Trust Co bought a new position in shares of Las Vegas Sands during the second quarter worth $210,000. Hedge funds and other institutional investors own 38.53% of the company’s stock.

Top 5 Casino Stocks To Invest In 2019: Aerohive Networks, Inc.(HIVE)

Advisors' Opinion:
  • [By ]

    Our Biggest Loser... And A Bunch Of Big Wins
    Our biggest loser was back in January when we closed out of small communications equipment firm Aerohive Networks (Nasdaq: HIVE). On January 17, the company made a statement about its upcoming fourth-quarter earnings release, warning that revenue would likely be near the lower end of its guidance range. Investors didn't take kindly to the news and sent shares tumbling by roughly 30%... well below our 15% trailing stop-loss. We ended up closing out with a 35% loss on the trade.

  • [By Stephan Byrd]

    Here are some of the news articles that may have effected Accern’s rankings:

    Get Anthera Pharmaceuticals alerts: Cystic Fibrosis Drugs Market – Future Growth Prospects and Industry Trends Analyzed Till 2025 (digitaljournal.com) Analysts Anticipate Anthera Pharmaceuticals Inc (ANTH) Will Announce Earnings of -$0.60 Per Share (americanbankingnews.com) News Buzz : Blink Charging Co. (NASDAQ:BLNK), Genocea Biosciences, Inc. (NASDAQ:GNCA), Anthera … (journalfinance.net) Current Lumpy Stocks:: Jounce Therapeutics, Inc. (NASDAQ:JNCE), Aerohive Networks, Inc. (NYSE:HIVE), Anthera … (journalfinance.net) Porous, non-porous tantalum cups yielded similar septic, aseptic risks after revision THA (healio.com)

    ANTH has been the topic of a number of research analyst reports. Zacks Investment Research upgraded Anthera Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Tuesday, February 13th. Jefferies Financial Group reiterated a “hold” rating and set a $0.50 target price on shares of Anthera Pharmaceuticals in a research report on Thursday, March 15th. Roth Capital initiated coverage on Anthera Pharmaceuticals in a research report on Wednesday, February 21st. They set a “buy” rating and a $10.00 target price on the stock. Finally, Piper Jaffray Companies downgraded Anthera Pharmaceuticals from an “overweight” rating to an “underweight” rating in a research report on Monday, March 12th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $3.44.

  • [By Max Byerly]

    Leidos (NYSE: LDOS) and Aerohive Networks (NYSE:HIVE) are both aerospace companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

  • [By Logan Wallace]

    Aerohive Networks Inc (NYSE:HIVE) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 573,420 shares, a drop of 35.3% from the May 31st total of 885,671 shares. Based on an average trading volume of 381,201 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.8% of the shares of the stock are short sold.

Top 5 Casino Stocks To Invest In 2019: Gorman-Rupp Company (GRC)

Advisors' Opinion:
  • [By Ethan Ryder]

    GridCoin (GRC) is a DPoR coin that uses the ProofofResearch hashing algorithm. It launched on November 3rd, 2013. GridCoin’s total supply is 390,312,753 coins. GridCoin’s official website is www.gridcoin.us. The Reddit community for GridCoin is /r/gridcoin and the currency’s Github account can be viewed here. GridCoin’s official Twitter account is @GridcoinNetwork and its Facebook page is accessible here. GridCoin’s official message board is cryptocurrencytalk.com/forum/464-gridcoin-grc.

  • [By Stephan Byrd]

    GridCoin (GRC) is a DPoR coin that uses the ProofofResearch hashing algorithm. Its genesis date was November 3rd, 2013. GridCoin’s total supply is 390,312,753 coins. The official message board for GridCoin is cryptocurrencytalk.com/forum/464-gridcoin-grc. The Reddit community for GridCoin is /r/gridcoin and the currency’s Github account can be viewed here. The official website for GridCoin is www.gridcoin.us. GridCoin’s official Twitter account is @GridcoinNetwork and its Facebook page is accessible here.

  • [By Max Byerly]

    GridCoin (GRC) is a DPoR coin that uses the ProofofResearch hashing algorithm. It was first traded on November 3rd, 2013. GridCoin’s total supply is 390,312,753 coins. GridCoin’s official Twitter account is @GridcoinNetwork and its Facebook page is accessible here. The Reddit community for GridCoin is /r/gridcoin and the currency’s Github account can be viewed here. GridCoin’s official message board is cryptocurrencytalk.com/forum/464-gridcoin-grc. GridCoin’s official website is www.gridcoin.us.

  • [By Logan Wallace]

    US Bancorp DE lessened its stake in shares of Gorman-Rupp (NYSE:GRC) by 3.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 136,614 shares of the industrial products company’s stock after selling 5,085 shares during the period. US Bancorp DE’s holdings in Gorman-Rupp were worth $3,996,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Gorman-Rupp Co (NYSE:GRC) Director Christopher H. Lake sold 2,000 shares of the firm’s stock in a transaction on Friday, August 17th. The stock was sold at an average price of $36.69, for a total value of $73,380.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

  • [By Joseph Griffin]

    Prentiss Smith & Co. Inc. acquired a new stake in shares of Gorman-Rupp Co (NYSE:GRC) during the second quarter, HoldingsChannel.com reports. The fund acquired 3,000 shares of the industrial products company’s stock, valued at approximately $105,000.

Top 5 Casino Stocks To Invest In 2019: Village Super Market Inc.(VLGEA)

Advisors' Opinion:
  • [By Ethan Ryder]

    BidaskClub lowered shares of Village Super Market (NASDAQ:VLGEA) from a hold rating to a sell rating in a report published on Tuesday.

    Shares of VLGEA stock opened at $27.20 on Tuesday. Village Super Market has a 52-week low of $21.95 and a 52-week high of $31.49. The company has a quick ratio of 1.38, a current ratio of 1.81 and a debt-to-equity ratio of 0.16. The firm has a market capitalization of $392.70 million, a price-to-earnings ratio of 13.80 and a beta of 0.04.

  • [By Logan Wallace]

    Village Super Market, Inc. Class A (NASDAQ: VLGEA) and Koninklijke Ahold (OTCMKTS:ADRNY) are both retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.

  • [By Shane Hupp]

    BidaskClub upgraded shares of Village Super Market (NASDAQ:VLGEA) from a sell rating to a hold rating in a research report report published on Tuesday.

  • [By Joseph Griffin]

    Media stories about Village Super Market, Inc. Class A (NASDAQ:VLGEA) have been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group identifies negative and positive press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Village Super Market, Inc. Class A earned a news impact score of 0.06 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 43.9608995956738 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Top 5 Casino Stocks To Invest In 2019: OncoSec Medical Incorporated(ONCS)

Advisors' Opinion:
  • [By Max Byerly]

    OncoSec Medical Inc (NASDAQ:ONCS) traded up 5.9% on Wednesday . The stock traded as high as $1.45 and last traded at $1.43. 506,563 shares changed hands during mid-day trading, a decline of 31% from the average session volume of 730,660 shares. The stock had previously closed at $1.35.

  • [By Logan Wallace]

    Here are some of the headlines that may have effected Accern Sentiment’s rankings:

    Get OncoSec Medical alerts: OncoSec Medical (ONCS) Given Buy Rating at Dawson James (americanbankingnews.com) OncoSec Presents Update from Triple Negative Breast Cancer Program at 3rd Global Insight Conference on Breast Cancer (finance.yahoo.com) OncoSec appoints Sara M. Bonstein as CFO and COO (seekingalpha.com) Oncosec Medical (ONCS) Appoints Sara M. Bonstein as CFO and COO (streetinsider.com) OncoSec Appoints Sara M. Bonstein as Chief Financial Officer and Chief Operating Officer (finance.yahoo.com)

    ONCS stock traded down $0.02 during trading on Thursday, reaching $1.28. The company’s stock had a trading volume of 367,800 shares, compared to its average volume of 916,959. OncoSec Medical has a 1 year low of $0.88 and a 1 year high of $2.95. The firm has a market capitalization of $68.05 million, a PE ratio of -1.21 and a beta of 2.98.

  • [By Stephan Byrd]

    HC Wainwright set a $4.00 price target on OncoSec Medical (NASDAQ:ONCS) in a research report released on Tuesday. The firm currently has a buy rating on the biotechnology company’s stock.

Top 5 Casino Stocks To Invest In 2019: Farmer Brothers Company(FARM)

Advisors' Opinion:
  • [By Stephan Byrd]

    BidaskClub upgraded shares of Farmer Brothers (NASDAQ:FARM) from a strong sell rating to a sell rating in a research note released on Friday morning.

  • [By Motley Fool Transcribing]

    Farmer Brothers (NASDAQ:FARM) Q4 2018 Earnings Conference CallSep. 11, 2018 5:00 p.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Farmer Bros Co (NASDAQ:FARM) CEO Michael H. Keown sold 23,333 shares of the business’s stock in a transaction that occurred on Monday, September 10th. The shares were sold at an average price of $28.03, for a total transaction of $654,023.99. Following the completion of the transaction, the chief executive officer now directly owns 68,405 shares of the company’s stock, valued at approximately $1,917,392.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

  • [By Lisa Levin] Gainers Carver Bancorp, Inc. (NASDAQ: CARV) shares jumped 92.1 percent to $7.01. iPic Entertainment Inc. (NASDAQ: IPIC) gained 21.6 percent to $9.73. Baozun Inc. (NASDAQ: BZUN) shares jumped 18.7 percent to $53.49 after reporting Q1 results. World Wrestling Entertainment, Inc. (NYSE: WWE) shares jumped 15.9 percent to $50.50. The company's "Smackdown Live" may not be renewed at NBCUniversal network and the company's "Monday Night Raw" program could be worth three times its current value elsewhere, according to a report for The Hollywood Reporter. Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) gained 14.7 percent to $ 20.46 after the company issued further details on Phase 3 ADVANCE study of ROLONTIS. Motus GI Holdings, Inc. (NASDAQ: MOTS) climbed 13.4 percent to $5.5009. Endocyte, Inc. (NASDAQ: ECYT) rose 13.3 percent to $ 14.23 after the company announced presentation of Phase 2 data from prostate cancer trial of 177Lu-PSMA-617 at the 2018 ASCO Annual Meeting. Diana Containerships Inc. (NASDAQ: DCIX) gained 12.9 percent to $1.7499 after the company announced the sale of Post-Panamax Container Vessel for $21 million. Essendant Inc. (NASDAQ: ESND) gained 12.7 percent to $12.43. Essendant confirmed receipt of unsolicited proposal from Staples of $11.50 per share in cash. Blink Charging Co (NASDAQ: BLNK) rose 11.8 percent to $8.04 after surging 31.68 percent on Wednesday. OptimumBank Holdings, Inc. (NASDAQ: OPHC) gained 11.5 percent to $5.15. Flotek Industries, Inc. (NYSE: FTK) shares climbed 10.7 percent to $3.74. Farmer Bros. Co. (NASDAQ: FARM) rose 7.9 percent to $25.95 after climbing 7.90 percent on Wednesday. Minerva Neurosciences Inc (NASDAQ: NERV) rose 6.5 percent to $6.93 after Journal of Clinical Psychiatry published positive results of cognitive performance from Phase 2B trial of roluperidone in schizophrenia patients. Williams Partners L.P. (NYSE: WPZ) rose 5.6 percent to $40
  • [By Motley Fool Transcribers]

    Farmer Brothers Co  (NASDAQ:FARM)Q2 2019 Earnings Conference CallFeb. 11, 2019, 5:00 p.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Farmer Brothers (FARM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Sunday, February 24, 2019

Solar Senior Capital Ltd (SUNS) Q4 2018 Earnings Conference Call Transcript

Logo of jester cap with thought bubble.

Image source: The Motley Fool.

Solar Senior Capital Ltd  (NASDAQ:SUNS)Q4 2018 Earnings Conference CallFeb. 22, 2019, 10:00 a.m. ET

Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

Operator

Good day, ladies and gentlemen. And welcome to the Solar Senior Capital Fourth Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to introduce your host for today's conference, Michael Gross, Chairman and Chief Financial Officer (sic) [Chief Executive Officer]. You can -- you may proceed.

Michael S. Gross -- Chairman and Chief Executive Officer

Thank you. Good morning. Welcome to Solar Senior Capital Limited's earnings call for the fiscal year ended December 31, 2018. I'm joined here today by Bruce Spohler, our Chief Operating Officer; and Rich Peteka, our Chief Financial Officer.

Rich, would you please start off by covering the webcast and forward-looking statements.

Richard L. Peteka -- Chief Financial Officer

Of course. Thanks, Michael. I'd like to remind everyone that today's call and webcast are being recorded. Please note that they are the property of Solar Senior Capital Limited, and that any unauthorized broadcasts in any form are strictly prohibited. This conference call is being webcast on our website at www.solarseniorcap.com. Audio replays of this call will be made available later today, as disclosed in our press release.

I'd also like to call your attention to the customary disclosures in our press release regarding forward-looking information. Statements made in today's conference call and webcast may constitute forward-looking statements, which relate to future events or future performance or financial condition. These statements are not guarantees of our future performance, financial condition or results, and involve a number of risks and uncertainties. Actual results may differ materially, as a result of a number of factors, including those described from time to time in our filings with the SEC. Solar Senior Capital Limited undertakes no duty to update any forward-looking statements unless required to do so by law. To obtain copies of our latest SEC filings, please visit our website or call us at (212) 993-1670.

At this time, I'd like to turn the call back to our Chairman and Chief Executive Officer, Michael Gross.

Michael S. Gross -- Chairman and Chief Executive Officer

Thank you, Rich. During a volatile fourth quarter in the capital market Solar Senior Capital delivered a strong operating performance, given the sell-off in the liquid leveraged loan market, which impacted the valuation for many of our private loans at year-end. SUNS net asset value was down 3% to $16.30 per share. Year-to-date the leverage loan index has already covered the majority of the fourth quarter sell-off. During the fourth quarter, SUNS delivered another consistent net investment income performance with GAAP NII of $0.35 per share for the fourth quarter covering our distributions. Also for the fiscal year, SUNS earnings of a $1.41 per share fully covered its distribution.

At December 31st, the fundamentals of our portfolio companies remain strong. At quarter-end over 98% of our comprehensive portfolio is invested in first lien senior secured loans comprised of approximately 40% asset-based loans and 58% cash flow loans. The general market consensus is that we are late in the credit cycle. Our defensive positioning in first lien loans and our niche specialty ABL verticals should enable us to perform well either during the downturn or continued strong economic environment.

Following the end of the year turmoil, we are seeing some positive signs in our pipeline of an improved upper middle market cash flow lending environment. As a reminder, Solar Capital Partners now has the ability to underwrite and hold across its platform first lien loan tranches of up to $200 million. This scale has achieved through two important strategic initiatives in 2018. The first initiative was a new asset coverage requirement. On October 11th, shareholders of SUNS and our sister BDC, SLRC, overwhelmingly approved the reduction in the asset coverage requirements, thereby accelerating the timing of the modification, which initially have been approved by the company's Board of Directors in early August. As a result, on October 12th, Solar Senior Capital's and our sister company Solar Capitals, asset coverage requirements changed from 200% to 150%.

Given our investment focus on senior secured first lien loan, which have been financed at much higher leverage levels in private funds and banks, we have increased our target leverage ratio to a range of 1.25 times to 1.5 times debt to equity. This new target range allows us for a meaningful and substantial cushion to both the net asset ratio requirement and leverage covenant on our credit facility, which we refinanced to accommodate the increase to the new regulatory leverage.

Importantly, we want to reiterate that the asset coverage modification will not change our investment strategy. It does, however, enhance Solar Senior Capital's ability to further expand our specialty finance lending platform. The consolidation of FLLP in the third quarter made possible by the new asset coverage ratio freed up significant 30% capacity, giving us the flexibility to make acquisitions and expand our specialty finance platform.

Our team has been actively targeting new verticals -- though during 2018, we were cautious as specialty finance company valuations became overheated. It appears the volatility in the fourth quarter has tampered some of these high valuations and we are carefully rebuilding our commercial finance acquisition pipeline. We intend to move closer to our new target leverage range by growing our portfolio over time when the market opportunity presents itself. Consistent with our long-standing conservative investment approach we will be prudent with the use of leverage. We view the increased leverage flexibility simply another investment and risk management tool.

The second initiative in 2018 involved increased the scale of SUNS investment advisors, Solar Capital Partners to enhance its role as a solutions provider with the ability to provide for up to $200 million in a given transaction, while maintaining conservatively diversified portfolios. Scale is particularly important given our focus in cash flow lending to upper middle market sponsor-owned companies, we believe are better resourced to withstand an economic decline than the smaller peers.

During 2018, SCP closed on $2.3 billion of incremental investable capital, including leverage, across two private credit funds and separately managed accounts that are now co-investing alongside Solar Senior Capital and Solar Capital. This brings total investable capital across the platform to approximately $5.4 billion. Most importantly, SUNS is already benefiting from SCP's enhanced scale and the form of new investments are only possible by having larger whole sizes and additional 30% capacity. Bruce will provide details on this important development shortly.

With leverageable 8.63 times net debt to equity at the end of the fourth quarter, SUNS is in a strong liquidity position. At December 31, 2018, when considering the combined credit facilities of SUNS balance sheet and at North Mill and Gemino, there's approximately $250 million of unused capacity across the platform subject to borrowing base limitations. We will continue to be highly disciplined in deploying our available capital.

At this time, I'd like to turn the call over to our Chief Financial Officer, Rich Peteka.

Richard L. Peteka -- Chief Financial Officer

Thank you, Michael. Solar Senior Capital Limited net asset value at December 31st was $261.4 million or $16.30 per share. This compares to a net asset value of $269.7 million or $16.81 per share at September 30, 2018. Solar Senior's investment portfolio at December 31, 2018, at a fair market value of $450.1 million in 47 portfolio companies operating in 20 industries, compared to a fair market value of $465.2 million in 49 portfolio companies operating in 21 industries at September 30th.

At December 31, 2018, SUNS net leverage decreased to 0.63 times from 0.7 times at September 30th. Solar Senior's new target leverage is 1.25 times to 1.5 times debt to equity under the reduced asset coverage requirement. From a P&L perspective, gross investment income for the three months ended December 31, 2018, totaled $10 million versus $11 million for the three months ended September 30th.

Net expenses for the three months ended December 31st were $4.4 million, compared to $5.3 million for the three months ended September 30th. Net investment income for the quarter ended December 31, 2018, was $5.6 million or $0.35 per average share, as compared to $5.8 million or $0.36 per average share for the three months ended September 30th. Below the line, Solar Senior had net realized and unrealized loss for the fourth quarter, totaling $8.2 million, compared to net realized and unrealized loss of $0.4 million for the three months ended September 30th. Accordingly, Solar Senior had a net decrease in net assets resulting from operations of $2.6 million or $0.16 per average share for the three months ended December 31st. This compares to a net increase in net assets resulting from operations of $5.4 million or $0.34 per average share for the three months ended September 30th.

Lastly, our Board of Directors declared a monthly distribution for March 2019 of $11.75 per share, payable on April 3, 2019, to stockholders of record on March 21, 2019.

At this time, I'd like to turn the call over to our Chief Operating Officer, Bruce Spohler.

Bruce J. Spohler -- Chief Operating Officer

Thank you, Rich. Before I provide an update on our fourth quarter activity. Let me take a minute to discuss our approach to valuation in light of the sell-off in the liquid leveraged loan market in the fourth quarter. As Michael mentioned, this resulted in a technical markdown of our portfolio's fair market value. It is important to remember that Solar Senior is not simply a portfolio of leveraged middle market loans. Relative to most of our BDC peers, we are a unique combination of commercial finance businesses, as well as a portfolio of senior secured upper mid-market cash flow loans.

Our valuation process is a combination of bottom-up fundamental credit analysis, with a top-down overlay, where we look to the market technicals and various market metrics from the leveraged loan market for our cash flow loans, as well as valuations of our peers specialty finance comparable companies for our commercial finance businesses. We have applied a consistent approach to valuations throughout our history and we believe that this bottoms up fundamental analysis coupled with a top-down market technical yield analysis is the right approach to providing fair market value. As of today, already approximately two-thirds of the fourth quarter market decline in leveraged loans has already recovered.

Now, turning to the portfolio. In the aggregate at year-end, our investments across our three business lines totaled just over $580 million. This highly diversified portfolio consists of a 161 borrowers with an average investment of approximately $3.6 million or 0.6% of our comprehensive portfolio. As Michael mentioned, the sell-off in the liquid leveraged loan market resulted in a technical markdown for our loans. The result -- the majority of our NAV decline quarter-over-quarter resulted from this technical factor, as well as softness in our commercial finance comparable companies set that we use for valuations as well.

Measured at fair value, close to 100% of SUNS portfolio consisted of senior secured loans, of which over 58% are in first lien cash flow loans, roughly 40% are in first lien asset-based loans and only 1.5% are in second lien secured loans, and less than one-tenth of 1% is in equity. Additionally, roughly 92% of loans have floating rate coupons, which should continue to benefit portfolio performance. Our fixed rate exposure comes from North Mill's factoring portfolio, which contains loans with much shorter duration and higher yields.

SUNS weighted average yield on a fair value basis for its portfolio at year-end was 10.5%. During the fourth quarter SUNS originated $83 million of loans and have repayments of approximately $83 million as well. In the face of the year-end volatility with questions concerning the Fed's direction on monetary policy, we balanced caution with taking advantage of approved -- improved select investment opportunities. Originations for all of 2018 totaled just over $260 million and repayments totaled just over $290 million.

Now, let me take a -- let me provide an update on our credit quality and earnings power of the portfolio. At year-end, 100% of SUNS portfolio was performing.

Now, let me turn to the investment verticals. Cash flow, at year-end our cash flow portfolio totaled $340 million, representing 58% of our comprehensive portfolio. The comp -- the cash flow portfolios comprised of loans to 47 borrowers with an average investment of $7 million. The fair value weighted average asset level yield was 8.1%, up slightly from the prior quarter. Our second lien cash flow exposure approximates 1.7% or $10 million of the $580 million portfolio. We expect this to continue decline over the coming quarters. Given our focus on maintaining a lower risk first lien portfolio, we have not made a new second lien investment in over four years. At year-end, the weighted average EBITDA of our first lien cash flow portfolio was approximately $100 million. Leverage to our investment security was 4.5 times on average and our interest coverage was 2.3 times on average.

In addition, the weighted average revenue growth of our portfolio companies was 9% increase and EBITDA was up 4.2% at year-end, reflecting continued positive trends in our portfolio company fundamentals. In the fourth quarter, we originated cash flow investments of $72.5 million and had repayments of $59 million. For the full year, we originated cash flow investments of $208 million and had repayments or amortization of approximately $218 million.

With the addition of the new private capital that we raised last year, which Michael referenced, SUNS is already benefiting from -- the platforms increased scale and ability to be a solutions provider. During the fourth quarter, SUNS was able to participate across the Solar platform in refinancing core wireless in ABRY Partners portfolio company in the form of an investment in their first lien refinanced loan. The platform broadly committed to $100 million hold for this first lien loan and SUNS was able to invest $12 million in this loan. The loan carries an all-in yield of just under 9%.

Now, let me update you on North Mill. At year-end, North Mill had a portfolio of approximately $122 million, which represented 21% of SUNS total portfolio. It consisted of loans to 80 different borrowers, with an average funded loan of $1.5 million. Weighted average asset level yield of North Mill's portfolio was 17%, which is elevated from prior quarters due to some one-time prepayment fees that we received in the fourth quarter.

During the fourth quarter North Mill funded new loans of $9 million and had repayments of $23.5 million. For the full year, North Mill funded $33 million of new loans and had repayments of $53.5 million. During the fourth quarter, North Mill exited including through liquidation, certain investments which they do in the ordinary course of their business activities. North Mill has selectively taken reserves against the portfolio for these loans and is working to maximize the recovery. During the fourth quarter, North Mill paid the company a cash dividend of $1.4 million, which equates to a 9% annualized yield.

Now, let me turn to Gemino. Gemino at year-end had a portfolio of $108 million, representing 18% SUNS total portfolio. It was comprised of 34 different loans with an average loan size of just over $3 million. The weighted average asset level yield for Gemino was 10.5%. During the fourth quarter, we funded roughly $2 million of new loans and had repayments of roughly $1 million. For the full year of 2018, Gemino funded $22 million of new loans and had repayments of $21 million. For the fourth quarter, Gemino paid SUNS a cash dividend of just under a $1 million, equating to an 11% yield.

In summary, as Michael mentioned, in cash flow lending we have begun to see an improved investment opportunity set for upper middle market loans, as well as our niche ABL markets. We believe Solar Capital Partners, with their increased investment capacity across the platform will result in more investment opportunities for SUNS in cash flow lending and specialty finance. We will not, however, stretch for yield by taking on more risk through either second lien loans or investments in more volatile cyclical industries.

Now, let me turn the call back to Michael.

Michael S. Gross -- Chairman and Chief Executive Officer

Thank you, Bruce. Since the 2011 inception of SUNS, our investment and management decisions have consistently been focused on building long-term value, protecting capital and maintaining alignment with our shareholders. In 2018, we put additional strategic building blocks in place in the form of reduced asset coverage requirements and enhanced platform scale to provide greater flexibility to drive long-term shareholder value. Importantly, we've been prudent in the face of sustained frothy credit markets and remain disciplined not compromising credit quality for yield. The result is a solid portfolio foundation from which to grow.

We maintained investment philosophy of assuming that we are late in the credit cycle and we believe that in the current environment it pays to be cautious. We remain to be seen whether the recent improvement in the upper middle market lending opportunities will be a lasting trend, but we believe through our differentiated origination platform and diversified portfolio that we are well-positioned to navigate through economic cycles.

At approximately 0.63 times net debt to equity, we are under-levered relative to our target range of 1.25 times to 1.5 times and we have substantial dry powder to deploy via our differentiated investment verticals. If the credit cycle does shift, we believe our history of conservatism will enable us to outperform on a relative and absolute basis, and we will be well-positioned to take advantage of market dislocations.

I would like to again, express our appreciation to our shareholders and banks for their overwhelming support to approve the adoption of the modified asset coverage ratio. The greater flexibility does not change our investment strategy rather it meaningfully enhances our ability to grow, build and potentially acquired niche specialty finance businesses as we continue to broaden our diversified commercial finance platform.

In addition, the reduced asset coverage requirement allows us to operate with an increased cushion to the regulatory leverage threshold, which should be a significant benefit in more volatile markets. At last night's close of $16.96 per share, SUNS carries a yield of 8.3%, which represents a significant pre -- discount to the 6.1% implied yield of the S&P/LSTA Leveraged Loan 100 Index. Given the overall credit quality of SUNS diversified portfolio, a differentiated origination engines and our disciplined investment philosophy, we believe SUNS represents an attractive investment on both the relative and absolute value basis.

We thank you for your time this morning and look forward to speaking to you in the next quarter. Operator, would you please open up the line for questions.

Questions and Answers:

Operator

Thank you. (Operator Instructions) And your first question comes from the line of Mickey Schleien with Ladenburg. Your line is now open.

Mickey Schleien -- Ladenburg -- Analyst

Yes. Good morning, Michael and Bruce. I just have one question this morning. If I'm not mistaken there was more deterioration in SUNS NAV on a relative basis than at Solar Capital, but I'm assuming the valuation methodologies are pretty similar, what factors can you attribute that difference to?

Michael S. Gross -- Chairman and Chief Executive Officer

Sure. I think it's hard to -- I don't want to spend too much time on this call talking about Solar. But I just think from a high level portfolio mix as you know is different at SUNS versus Solar in terms of Solar having life sciences, having equipment finance, having Crystal, whereas SUNS has Gemino and North Mill. So, the comp sets that we look to are different and are weighted differently, given their contribution to the overall portfolio. Obviously, cash flow loans are bigger percentage also, Mickey, of SUNS portfolio than Solar's, and so they're going to look more directly to loan index, so it's a combination of mixed factors.

Mickey Schleien -- Ladenburg -- Analyst

Thank you for that. That's all -- those are my only questions this morning.

Michael S. Gross -- Chairman and Chief Executive Officer

Great. Thank you very much.

Operator

Thank you. (Operator Instructions) And your next question comes from the line of Finian O'Shea with Wells Fargo Securities. Your line is now open.

Finian O'Shea -- Wells Fargo Securities -- Analyst

Hey, guys. Good morning, again. Just a higher level market question in regards to your additional emphasis on first lien, just real large this is something that, frankly, I can't remember the time I've heard anyone not say this in most data points or anecdotes point to the -- all of the middle market private credit capital formation revolving around senior debt, and it also seems that second lien has gapped out a little bit or might, perhaps, directly because of this or we have -- perhaps because they tend to be larger credits and are more liquid. So, if you understand what I'm saying, I'm sure by now, where -- how do you look at this. How much more do these -- do the senior and junior markets have to diverge before you really give this a harder look?

Michael S. Gross -- Chairman and Chief Executive Officer

Sure. As you know, because we have our commercial finance businesses and this is true at both platform SUNS and SLRC, as a meaningful part of the portfolios they tend to be higher yielding, and most importantly, for us, they have real covenants and borrowing bases. That's true to North Mill and Gemino, and as well as the Crystal NEF platforms and life science over at Solar. So, for us it's much less, Finian, about where yields are. Obviously, we want to make as much money as possible on each investment, but it really starts with what are the structural protections. What are the covenants. What are the leverage levels. And what are the sacred rights in these documents. And that's what troubled us over the last couple of years is the degradation of terms rather so much than price compression.

And so, what we're really looking for is terms that come back into the documents in the cash flow market. It's been a very long time since we've seen them in the second lien sector, which is why we haven't made a second lien investment in four years. The first lien loans, they do come back quickly during periods of volatility. And we saw a couple of those, we highlighted core. We're able to actually have covenants in Q4 and a few others. So, that's really what will drive our behavior. We can get terms. We'll blend out a nice attractive portfolio yield between cash flow and commercial finance assets, but we want to see real teeth regardless of whether it's a cash flow loan or a commercial finance loan.

Finian O'Shea -- Wells Fargo Securities -- Analyst

Thank you for the color.

Michael S. Gross -- Chairman and Chief Executive Officer

Thank you.

Operator

Thank you. (Operator Instructions) And I'm not showing any further questions at this time. I would now like to hand the call back over to Michael Gross, Chairman and Chief Executive Officer for any closing remarks.

Michael S. Gross -- Chairman and Chief Executive Officer

Hi. We've noticed the comments, but we thank you for your time and your support. Have a good day.

Operator

Ladies and gentlemen, this concludes today's conference. Thank you for participating and have a wonderful day.

Duration: 31 minutes

Call participants:

Michael S. Gross -- Chairman and Chief Executive Officer

Richard L. Peteka -- Chief Financial Officer

Bruce J. Spohler -- Chief Operating Officer

Mickey Schleien -- Ladenburg -- Analyst

Finian O'Shea -- Wells Fargo Securities -- Analyst

More SUNS analysis

Transcript powered by AlphaStreet

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

Saturday, February 23, 2019

ProAssurance Corp (PRA) Q4 2018 Earnings Conference Call Transcript

Logo of jester cap with thought bubble.

Image source: The Motley Fool.

ProAssurance Corp  (NYSE:PRA)Q4 2018 Earnings Conference CallFeb. 22, 2019, 9:30 a.m. ET

Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

Operator

Good morning, everyone. Welcome to ProAssurance's Conference Call to discuss the Company's Fourth Quarter and Full Year 2018 results. These results were reported in a news release issued on February 21, 2019, and in the company's annual report on Form 10-K, which was also filed on February 21st. These documents are intended to provide you with important information about the significant risks, uncertainties and other factors that are out of the company's control and could affect ProAssurance's business and alter expected results.

We also caution you that management expects to make statements on this call dealing with projections, estimates and expectations and explicitly identifies these as forward-looking statements within the meaning of the U.S. Federal Securities Laws and subject to applicable safe harbor protections.

The content of this call is accurate only on February 22nd, 2019, and except as required by law or regulation, ProAssurance will not undertake and expressly disclaims any obligation to update or alter information disclosed as part of these forward-looking statements. The management team of ProAssurance also expects to reference non-GAAP items during today's call. The Company's recent news release provides a reconciliation of these non-GAAP numbers to their GAAP counterparts.

Now as I turn the call over to Mr. Frank O'Neil, I would like to remind you that the call is being recorded, and there will be time for questions after the conclusion of prepared remarks.

Frank B. O'Neil -- Senior Vice-President and Chief Communications Officer

Thank you, Denise. On our call today are our Chairman and CEO, Stan Starnes; President and Chief Operating Officer, Ned Rand; and Chief Financial Officer, Dana Hendricks; Howard Friedman and Mike Boguski, the Presidents of our Healthcare Professional Liability and Workers' Compensation operations are also on the call.

And we are going to go first to Stan.

William Stancil Starnes -- Chairman, Chief Executive Officer and President

Thank you, Brian. As I said in our earnings release, 2018 has not been without its challenges, especially given the volatility in the equity markets, which had such a negative effect on our net income in the quarter, the effects of an evolving loss environment in our medical professional liability line and the higher-than-expected property and natural catastrophic losses in our Lloyd's investment. I mentioned those first, so as not to be seen as glossing over the challenges, but you will hear a number of positives in this call as well.

Our Workers' Compensation insurance segment is achieving excellent results despite a very competitive market. We are seeing clear signs of market firming in our medical professional liability business, with higher pricing and strong retention. After we complete our remarks on this quarter, we will discuss the management changes we announced yesterday. But first, we'll give some high level comments on consolidated results from Ned.

Edward Lewis Rand Jr. -- President and Chief Operating Officer and President of Medmarc Insurance Group

Thank you, Stan. Top line growth was again a highlight for us in the fourth quarter and for the year. For the quarter, consolidated gross premiums written were $212 million, an increase of $20 million or 10.4% over the same quarter in the prior year. This contributed to a year in which total gross premiums written reached a record $957 million, an increase of $82 million or 9.4% over 2017, with year-over-year growth in all of our operating segments. This success was due in part to almost $100 million in new business written through our domestic operations in 2018. A key indicator to us that our products are successfully differentiated in a very competitive market.

For the fourth quarter, gross premiums written grew 7.7% or $4.6 million in our Workers' Compensation Insurance segment and 3.9% or $635,000 in our Segregated Portfolio Cell Reinsurance segment quarter over quarter to $65 million and $17 million respectively. In our specialty P&C segment, gross premiums were essentially unchanged quarter-over-quarter, primarily due to timing differences which Howard will touch on later.

Gross premiums written in our Lloyd's segment increased to $25.8 million. While we are pleased with this top line growth, there are significant challenges that must be met to carry that growth to the bottom line. The consolidated current accident year net loss ratio for the quarter was 88.6%, up seven points over last year's fourth quarter. This was primarily due to two factors. First, the higher-than-expected property and natural catastrophe-related losses in our Lloyd segments, which we will discuss in greater detail shortly and the continuing caution we apply to our loss bps in light of the potential for increased loss severity within our medical professional liability lines.

As we've said before, we believe that caution will continue to affect our valuation of potential loss trends and reserves within our specialty P&C segment for the foreseeable future. In the meantime, we continue to benefit from strong retention in our domestic insurance operations and are encouraged by growing evidence of the return to rational pricing and underwriting in the medical professional liability market. Combined with over $23 million in new business written in the fourth quarter of 2018 to our specialty P&C and Workers Compensation Insurance segments. These factors served to highlight our ability to increase premiums and add business while maintaining our underwriting discipline. We continue to grow market share by providing real value to our policyholders.

I'm going to ask Dana to share some highlights on the non-insurance related results in the quarter. Dana?

Dana Shannon Hendricks -- Chief Financial Officer

Thanks, Ned. On a consolidated level, our net investment result was $20.9 million, a decline of $4.7 million as compared to the fourth quarter of 2017, attributable to a decline in both net investment income as well as equity in earnings from unconsolidated subsidiaries. The decline in net investment income of $1.9 million quarter-over-quarter reflected lower average investment balances, particularly in our muni-bond portfolio as we have reduced that asset class as a result of tax reform.

This was partially offset by an increase in income from our equity securities, which reflects an increase in our equity allocation. The decrease in equity in earnings of unconsolidated subsidiaries of $2.8 million quarter-over-quarter was primarily due to the volatility of the broader equity market, which led to lower reported earnings from a few LP investments and an increase in tax deductible operating losses associated with our tax credit investments.

Net realized investment losses for the quarter totaled $46.1 million, primarily due to mark-to-market adjustments on our equity trading portfolio. Importantly, the recovery in the equity market since the first of the year has reversed about $32 million of that loss. The net realized investment losses were the primary drivers of the consolidated net loss for the quarter of $24.4 million or $0.46 per diluted share. Non-GAAP operating income for the quarter was $9.7 million or $0.18 per diluted share. As of December 31st, we held approximately $236 million in unpledged cash and liquid investments outside our insurance subsidiaries. This brings us to capital management. We did not repurchase any shares in the quarter or the year for that matter, as the price did not reach a level where we felt repurchasing was our best use of capital.

I'll remind you that we target a 36-month or shorter payback period when contemplating buying above book value, which we believe removes the motion from the decision about repurchases. We have approximately $110 million still available in our Board-authorized stock repurchase program. We will continue to evaluate our capital position with our Board on a regular basis, keeping in mind factors such as capital requirements imposed by regulators and rating agencies and the opportunities to add business as we see potential changes in the market. That includes writing new business or through the M&A. Frank?

Frank B. O'Neil -- Senior Vice-President and Chief Communications Officer

Thank you, Dana. Now we're going to go to Howard and Mike for commentary on our operating segments domestically, Howard, will you start?

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

Thanks, Frank. The results of our specialty P&C segment continued to be affected by our consideration of potentially higher severity trends, especially with regard to large complex risks. Again, we have not seen these trends manifest within our paid losses, but we remain concerned about increasing severity in the broader market. To that effect, net favorable loss development was $22 million compared to $37 million in the year ago quarter and $77 million for the year, compared to $119 million in 2017.

That said, I believe there are positives to consider that highlight the underlying strength of the segments and its future. First, even though the fourth quarter was flat over the same quarter in the prior year, we saw an increase in gross premiums written of 5.1% for the year over 2017. The year-over-year gain was driven largely by an increase of $17 million in healthcare facilities premiums or 36.3% quarter-over-quarter.

As the trends of consolidation and migration of physicians from independent practices to hospital-based medicine progresses, healthcare facilities continue to be an important focus for us. Retention in healthcare facilities increased to 88% in the quarter, up five points over the same quarter in 2017 and retention for the year was 87%, up one point over last year.

In addition to a 7% price increase on healthcare facilities renewals, both for the quarter and the year, we generated $7 million in new business in the quarter, up from approximately $800,000 in the same period of 2017. This reaffirms that we are succeeding in the marketplace and building on our ongoing visibility in the broker community, which largely controls the facilities business.

In the fourth quarter, we wrote $5 million in physician new business. However, gross premiums written in our physician business declined by $4 million quarter-over-quarter. The decreased top line premium was due primarily to the timing of the renewal of a few large policies, that shifted $5 million of expiring premium into the first quarter of 2019. Physician retention was down four points to 88% for the quarter, but flat at 90% year-over-year. Physician renewal pricing increased by 2% and 3% for the quarter and the year respectively. These rate increases are from the market conditions that we have discussed for several quarters and are consistent with the beginning of a firmer market, as expectations of severity claim, we would expect pricing to follow. While we believe that ProAssurance will benefit as the market reacts to emerging loss trends, we want to underscore our continuing dedication to protecting the strength of our balance sheet. That requires that we take a cautious view of the potential for a rise in severity, which in turn influences our loss fix and colors the evaluation of our reserves.

Our current accident year loss ratio increased by almost seven points to 100.3% in the quarter and by almost four points to 93.8% for the year. A significant portion of the increase in loss ratio for the quarter and less so for the year, was due to an increase in ceded premiums, which reduced the denominator of the loss ratio. The loss portfolio transfer in the second quarter also increased the loss ratio for the year, since it had very low expenses and therefore, a higher loss ratio.

Finally, with a broader loss environment continuing to show signs of increased severity, we selected higher initial loss ratios in certain portions of our business to reflect the caution expressed above. We believe that it is more important than ever to establish and evaluate reserves with the conservatism that has resulted in success over the years. So, the bottom line is that we see no signs that these trends will change in the near future, meaning you should expect our reserve and loss severity assumptions to continue to affect this segment in 2019.

Before I turn it over to Frank, I want to emphasize that these trends and projected loss severity have an equal and perhaps greater influence on our competitors, especially those who have made a grab for market share at the expense of the quality of their balance sheets, while the market was softer. As the market continues to provide challenges, the rewards of conservative reserving practices and rational pricing are paid back with interest. The proof is in the pudding as the saying goes and a prime example is our Medical Technology and Life Sciences business, which for the year added $35 million of gross premiums to our top line and $14 million to our bottom line, primarily as a result of favorable development. Further, the Life Sciences combined ratio for the year was 40.2%, that kind of profitability is made possible by resisting the temptation to write easy business in lieu of good business.

Frank?

Frank B. O'Neil -- Senior Vice-President and Chief Communications Officer

Thank you, Howard. Mike, you're up next to discuss both of our Workers Compensation focus segments.

Michael Leonard Boguski -- President of Eastern Insurance

Thank you, Frank. The Workers' Compensation Insurance segment operating results increased 35% to $14.3 million for 2018, compared to $10.6 million for 2017. This was driven by an increase in net premiums earned and a decrease in the underwriting expense ratio, partially offset by an increase in the net loss ratio. During the year, gross premiums written, which includes traditional business and the alternative market business ceded to the SPC Reinsurance segment increased 11% to $293.2 million, compared to $264 million for 2017, an increase of $29.2 million.

This was driven by consistent production results and strong retention, including the Great Falls Insurance Company renewal rights transaction. New business writings for 2018 were $51.5 million compared to $47.7 million in 2017, including $11.7 million of new business related to Great Falls. Audit premium was $5.9 million as compared to $4.1 million in 2017. Renewal prices decreases were held to 1% during 2018, compared to renewal price decreases of 3% in 2017.

We are pleased with our premium retention rate of 86% for the year, a solid result in an increasingly competitive Worker's Compensation marketplace, where retention rates at that level are increasingly difficult to achieve. The increase in the calendar year net loss ratio reflecting an increase in the current accident year net loss ratio, partially offset by favorable trends in prior accident year claim closing patterns, resulting in net favorable development of $8 million in 2018, compared to $5.7 million in 2017.

The 2018 net favorable loss reserve development reflected better than expected claim results, primarily related to accident years 2015 and 2016. The increase in the current accident year net loss ratio from 66.1% in 2017 to 68% in 2018 is due to an increase in severity related claim activity related to economic growth trends. The claims operation closed 64.2% of 2017 and prior claims during 2018, indicative of the short tail nature of our Workers' Compensation business model.

The decrease in the full year 2018 underwriting expense ratio primarily reflected the effect of the increase in premiums earned and the continued effective management of general expenses. The combined ratio of 93.6% improved approximately one point in 2018 compared to 2017. The 2018 combined ratio includes 1.3 percentage points of intangible asset amortization, and 0.8 percentage points of a corporate management fee.

I want to highlight a few items in the Workers' Compensation insurance results for the fourth quarter of 2018. Gross written premium increased almost 8% over the same period in 2017 and the combined ratio was 88.2%, including a calendar year net loss ratio of 60.4% in an underwriting expense ratio of 27.8%. The Workers' Compensation Insurance segment operating results increased $6.6 million for the fourth quarter of 2018, compared to $5.1 million for the same period in 2017, an increase of 30%.

Two important strategic initiatives that were launched in 2017, continue to produce profitable premium in 2018. The Great Falls Insurance Company renewal rights transaction which now serves as our New England regional office, added $15 million of direct written premium in 2018. And the Eastern Specialty Risk higher hazard employer (ph) unit, which launched in 2017 contributed $8.2 million.

Now I'd like to focus on the segregated portfolios to our Reinsurance segment. The segment's operating result of $2.3 million for 2018 represents our share of the net operating profit of the segregated portfolio cell captive programs, in which we participate in varying degrees. Gross written premium in the SPC Reinsurance segment increased to $85.1 million for 2018 from $77.7 million in 2017. This includes flat renewal pricing in 2018 compared to renewal price decreases of 4% in 2017.

Production results for 2018 include the premium renewal retention of 91% and new business writings of $8.3 million, which were ceded to the SPCs from the Workers' Compensation Insurance segment. Year-over-year, the SPC 2018 calendar year net loss ratio decreased to 52.4% from 54.9%, driven by net favorable development of $9 million in 2018, compared to $8.5 million in 2017, and a decrease in the current accident year net loss ratio. The favorable development reflects better than expected claim results, primarily related to accident years 2015 through 2017. The current accident year loss ratio was 64.5% for 2018, compared to 67.4% in 2017. The decrease in the current accident year net loss ratio is due to a decrease in large claim activity in 2018 compared to 2017. Underwriting expenses in the SPC reinsurance segment represent the ceding commission paid to the Workers' Compensation Insurance and specialty P&C segments for the services provided to the SPC business.

Frank?

Frank B. O'Neil -- Senior Vice-President and Chief Communications Officer

Thank you, Mike. Howard, back to you now for some commentary on Lloyds.

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

Sure. Frank. Please remember we are reporting on a one quarter lag as we have since the inception of the segment. However, in quarters such as this one, where material effects of an event are either known or projected, we have accelerated certain results into the current reporting quarter.

The additional net pre-tax loss costs from exposure to Hurricane Michael were $6.8 million, net of reinsurance and reinstatement premiums. Normally, these losses would be reported in our first quarter of 2019, due to the aforementioned quarter delay. However, due to the availability and materiality of these estimates, we have accelerated our reporting of these storm-related losses into our fourth quarter of 2018. Segment operating results for the quarter also included our allocated share of the estimates for losses in connection with certain other natural catastrophes, which included volcanic eruptions in Hawaii and Hurricane Florence, which affected several states along the mid-Atlantic.

We estimate our allocated share of a net pre-tax losses associated with these natural catastrophe and property losses to be approximately $3.2 million, which brings our total natural catastrophe-related losses to approximately $10 million in the quarter. The current accident year net loss ratio was 104.5% for the quarter and 74% for the year. We recognized $1.7 million in adverse development in the quarter. This drove adverse development for the year to $2 million as compared to favorable development of approximately $800,000 in 2017.

As Ned mentioned earlier, gross premiums written were $25.8 million. The increase is due primarily to our greater participation in the operations of Syndicate 1729 from 58% to 62% effective January 1st and our 100% participation in Syndicate 6131, which is the special purpose arrangement written through Syndicate 1729. Gross premiums written in the quarter also increased, albeit to a lesser extent by the effect of reinstatement premiums received of $913,000 in 2018, as compared to $234,000 in 2017 in connection with natural catastrophe-related losses. For the year, gross premiums written increased 26.4% to $88.7 million.

Net premiums earned increased $6.2 million to $18.1 million, an increase of 52.1% over the prior year quarter. As in prior quarters, this primarily reflected the increased amount of business produced in the open market, where premium is earned over 12 months, as opposed to business written under -- delegated underwriting authority where premium is earned over 24 months. The growth in expenses continues to result from the addition of staff needed to accommodate the segment's growth and by higher commissions resulting from premium growth. The increase in gross premiums written mentioned earlier is a step in the right direction toward achieving the necessary scale for the Syndicate to reduce the impact of operating expenses.

Frank?

Frank B. O'Neil -- Senior Vice-President and Chief Communications Officer

Stan, I know you want to make some comments about Lloyds.

William Stancil Starnes -- Chairman, Chief Executive Officer and President

Thanks, Frank. As we said in our pre-release, we are disappointed in the financial results of our investment at Lloyd's. While we believe the reasons we decided to invest in Lloyd's are still valid. We also understand that investors are concerned with the financial performance of this investment and the volatility, it has introduced into our results. As we said, we are undertaking a review of all of our options with this investment in an effort to reduce both the financial significance of the investment and the associated earnings volatility.

As we are just beginning this process, we cannot yet project what the ultimate result will be. We continue to believe in what (inaudible) underwriting has created and want to help position the Syndicate for long-term success. Our evaluation will be comprehensive and will include a range of all alternatives including finding ways to reduce the volatility of the Syndicate's resolve through partial reinsurance of our participation or reducing the capacity we provide. We are not going to rush into anything, but we recognize the importance of resolving this and we will not drag our feet in reaching the final determination of the best course of action for ProAssurance and our investors.

Now I would like ask Ned to discuss the management changes that we announced yesterday afternoon. Ned?

Edward Lewis Rand Jr. -- President and Chief Operating Officer and President of Medmarc Insurance Group

Thank you, Stan. As we noted in our press release, Howard has indicated his desire to retire from the day-to-day activities of running our Healthcare Professional Liability business and we have reluctantly agreed. We are pleased that he will continue to play an important role in the organization going forward. We and our investors owe Howard a deep debt of gratitude for his years of service, insight and wisdom. It's a debt, we can never repay. Rather than have me address his reasons for stepping away from some of his many duties, I thought it's best that you hear from him, Howard?

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

Thanks, Ned. And thank you to Stan, Mike, Dana, and everyone else at ProAssurance who have been so gracious, supportive and understanding of my decision. I spoke to several hundred of our ProAssurance associates yesterday afternoon and I will tell you what I told them. I love what I do, and I get a great deal of satisfaction, enjoy every day. After more than 22 years of ProAssurance and almost 40 years in the medical professional liability business, there's still something new, interesting and professionally challenging every day. I'd love to lead such a great group of people through the next portion of the market cycle, with all of the challenges and satisfaction that will come from it.

At the same time now, there are many other things I'd like to do, time with my grandchildren, hobbies, travel and many other interests. My wife and I want to do those things while we can, while we are healthy and active. I'm very happy that I'll be able to have a continuing, but limited role with ProAssurance after mid-May and contribute in a small way to its ongoing success. I also want to personally thank many of you out there on this call for the years of meetings, friendship and support, even with your tough questions. Thanks, everyone.

Edward Lewis Rand Jr. -- President and Chief Operating Officer and President of Medmarc Insurance Group

Thanks, Howard. As a result of Howard's decision, we've been able to create new opportunities for Mike Boguski and Kevin Shook. Both Mike and Kevin has proven to be great assets for ProAssurance. I'm excited for them and for ProAssurance. Mike understands the history of this side of our business and a culture of service excellence that has evolved from that history. He also understands the bottom-line expectations that we honor and I'm sure his operational insights will be of value in improving everything we do.

Kevin knows Eastern's operations inside and out and has been a vital part Eastern's success. I'm confident, he will ensure that our Workers' Compensation operations continue in the upward trajectory that Mike has launched. Mike and Kevin, any remarks from your end?

Michael Leonard Boguski -- President of Eastern Insurance

Ned, I'll start. First of all, I'd like to thank, Stan and Ned for the opportunity to lead the Specialty Property and Casualty segment into the future. I look forward to the challenges and opportunities ahead with a great deal of enthusiasm. I want to congratulate Howard on a truly outstanding career. It's been a truly fantastic experience to work alongside Howard over the past five years. I also look forward to working with Howard in his actuarial role in the organization and to benefit from his vast healthcare industry experience and institutional knowledge. Thank you, Howard from all of us.

I want to express my deep gratitude and appreciation to the Eastern team members, senior executives, agency partners and strategic business partners for their tremendous support, dedication and commitment over the past 22 years. Together, we have built an industry-leading Workers' Compensation specialists from the start-up position in 1997 to a $290 million top line business at year-end 2018, that has consistently delivered an attractive underwriting result over the various economic and insurance cycles. I'm extremely proud of all that we've accomplished together over the past 22 years. Thank you so much.

I want to finish by congratulating Kevin Shook and the well deserved promotion to the President of Eastern. I'm extremely confident that Kevin will lead the Workers' Compensation and SPC reinsurance businesses to the next level of success. He's battle-tested and very well prepared for this leadership role. He brings a wealth of talent, experience, leadership skills, work ethic and energy to the organization in his role. On a personal level, Kevin has been a trusted advisor, a valued business partner and a great friend over the past 18 years. I'm extremely grateful that this strong relationship will continue in our new executive leadership roles in the ProAssurance organization.

Thank you, Kevin so much.

Kevin M. Shook -- Executive Vice President-Eastern Alliance Insurance

And thank you, Mike. I would like to begin by expressing my gratitude to you Mike, Stan and Ned for the opportunity to become Eastern's second President since its founding in 1997. I've been with Eastern for almost 18 years beginning first as it CFO until January of '14 when I was promoted to Executive Vice President, overseeing all field operations and our captive business. I would like to thank our dedicated employees, agency partners and strategic business partners for the valuable contributions to Eastern over the years. Together, we will lead the Workers' Compensation and SPC businesses to the next phase of success.

I would also like to congratulate Howard on an outstanding career and wish him continued success in his new actuarial role. I'm especially grateful to Mike, Mike is a great mentor friend and trusted partner. Mike has led Eastern strategic vision, operational and financial discipline and energetic culture and has been very collaborative in these endeavors, which is prepared me well for the future. I look forward to Mike's leadership in our Specialty P&C business and the enthusiasm, innovation, dedication talent and experience that he will bring to this new role.

I'm now going to turn it back to Stan for closing remarks.

William Stancil Starnes -- Chairman, Chief Executive Officer and President

Thank you, Kevin. I'll conclude by again noting our gratitude to Howard, Mike and Kevin, for their past service and for their anticipated future contributions. There will be ample opportunity in our May call, to more fully comment on these changes and on our ongoing gratitude, Frank?

Frank B. O'Neil -- Senior Vice-President and Chief Communications Officer

Thank you, Stan. Denise, that concludes our prepared remarks. We open the lines for questions.

Questions and Answers:

Operator

Certainly sir. We will now begin the question-and-answer session. (Operator Instructions) And your first question this morning will come from Amit Kumar of Buckingham Research. Please go ahead.

Amit Kumar -- Buckingham Research -- Analyst

Thanks and good morning. And Howard, on your retirement news, thanks for all the help over the years, it's been great to learn so much from you on different topics.

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

Thank you, Amit.

Amit Kumar -- Buckingham Research -- Analyst

And then, maybe I just have a few questions on Lloyd's and then I'll requeue. The first question I had was -- let me ask it, since there is -- probably there is no way to ask this, was that your desire to retire, was it accelerated by what's going on at Lloyd's or not?

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

I'll say no, absolutely not. I tried to state the reasons, and those are 100% the reasons. Lloyd's is a -- I believe a good long-term business in general and I think as Stan said, we have to look at the options for ProAssurance, but no, nothing to do with Lloyd's, all to do with me, unfortunately.

Amit Kumar -- Buckingham Research -- Analyst

Yeah. And on the outside, I can look the timing of press release coinciding with strategic options just made me wonder. Moving on, I wanted to better understand Lloyd's -- I know we spent a lot of time in 2013 and 2014 understanding this. The first question I had, is there noise coming mostly from the 6131 piece, that the special, that the contingency and the specialty property business or is this from 1729?

Edward Lewis Rand Jr. -- President and Chief Operating Officer and President of Medmarc Insurance Group

Hey, Amit, it's Ned. As we said in our release and in the prepared remarks, the impact is coming from catastrophe losses -- property catastrophe losses and those are associated with 1729. As we discussed in the past, there's essentially three lines of business or buckets of business in 1729, right. It's got a nice casualty book of business, it has a specialty property book of business and a property reinsurance business, it includes property cat.

In 2017 and 2018, there's been two very challenging back-to-back catastrophe years. In 2017, you had three hurricanes coming together to form very large significant losses for the industry and in 2018, it's been more of a frequency of severity with no individual event being as big as those in 2017, but just a lot of sizable events coming together in 2018, but it's all really been within the core of 1729.

Amit Kumar -- Buckingham Research -- Analyst

Got it. And then the next question, again staying on Lloyd's is, that the $200 million capital commitment, is that some sort of a contractual commitment, i.e, you know, we are pretty much set for 2019. And I guess any actions can only be peripheral at this time, i.e., no reinsurance et cetera, and then 2020 when your six-year commitment ends, then things change or how should I think about that piece?

Edward Lewis Rand Jr. -- President and Chief Operating Officer and President of Medmarc Insurance Group

It's a good question, Amit. So for, I think for 2019, as far as the capital that we've committed kind of following though the Lloyd's process, we have made a commitment to the Syndicate for 2019 and that capital is committed. Now there are things that we potentially can do and we'll evaluate using reinsurance as Stan said to dampen and mute some of the volatility that we've seen and that's kind of independent of that capital commitment and we can effect that at any time. So, the commitment is therefore for 2019 and then as we work toward 2020 as Stan mentioned, one of the things that we will be evaluating is whether or not we should reduce that capital commitment by bringing in other capital providers into the syndicate and that's something that we'll evaluate as well.

Amit Kumar -- Buckingham Research -- Analyst

Got it. That's actually very helpful. The only, the final question and I will stop here is, going back to the -- I was going to use the term core, the medical professional liability business line and talking about the discussion on loss cost trend. I actually was going back and reading some of your transcripts from when we started talking about it. This might be for Howard. When we look at the time when we started talking about it initially, and when we look at it today and I know that one common theme is, I mean you commented that these losses haven't yet manifested themselves in the paid losses and yet you remain concerned. Has anything changed from the time-frame when you were initially talking about it? Is it changing faster, slower? Any comparative you would be -- very helpful Howard and I will stop here. Thanks again.

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

Sure. Well, I think what I'd say is we have not, and so really don't see the effects in our paid losses, so that aspect has not changed. We continue to see a lot of severity related activity in the general news related to large verdicts and settlements for both physician and hospital clients. Some of it I think as we spoke about before, probably driven by higher available coverage limits with the consolidation in healthcare, larger entities, purchasing larger limits and therefore, more resources available to -- as a target.

The only thing I'd say that has changed from our perspective is that, we're continuing to see those things. It wasn't just an aberration at least in terms of the news items and the experience in the judicial system and we're still working through that. The lag -- the time lag as you know for resolution of claims in this business is measured in years. So, it will be a little longer, I think before we can confirm whether there is an effect on our paid losses or if we are going to find that we've been conservative in the approach that we're taking on a reserve side.

Amit Kumar -- Buckingham Research -- Analyst

Got it. Okay, that's very helpful. And Howard once again thanks for all your help over the years.

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

You're welcome. Great to know you. Thank you, Amit.

Operator

The next question will be from Mark Hughes of SunTrust. Please go ahead.

Mark Hughes -- SunTrust -- Analyst

Thank you very much. Good morning.

Frank B. O'Neil -- Senior Vice-President and Chief Communications Officer

Good morning, Mark.

Mark Hughes -- SunTrust -- Analyst

My congratulations as well that everyone in their new roles. On the current accident year losses in the Specialty P&C, you mentioned those -- the impact of the denominator, I guess with the ceded premiums, higher reduced denominator and I assume that's around the facilities business, how do we think about that on a go-forward basis? The full year, current accident year, if I'm looking at this properly (ph) is 94%. Is that a good a barometer going forward?

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

I think certainly the full year is a better barometer going forward the -- in the fourth quarter, the increase in the ceded premium is really a result of the adjustment for those prior year reinsurance contracts that had retrospectively rated premiums and adjustment that came from the increase in the loss estimates. So in other words, obviously, a follow through of increasing losses i.e. increasing ceded losses resulting in more ceded premium accrual and those years that had the retrospectively rated reinsurance contract, we're moving farther away from them for the most part it's 2015 and prior with respect to premiums that can go up as well as down. So, I certainly think that the full year loss ratio estimate is a better gauge, obviously it's going to depend on what we see in those -- in loss activity in 2019 and from which years it comes.

Mark Hughes -- SunTrust -- Analyst

And -- when I think about your experience in the fourth quarter, and this is just a one quarter snapshot, but the physician pricing up 2%, the retention was a little lower in the high 80%s, still very good clearly, but a little bit lower, but on the other hand, you continue to see signs of severity related issues. Why is -- are your competitors still not responding to this environment?

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

It varies like whatever the things that we certainly see some competitors that are responding or in terms of, say, being less competitive, if you will and we see others that aren't either ignoring it, not seeing it in their numbers or not seeing it yet. It's hard to tell exactly what the rationale is. Our retention and price change as you know, will vary from quarter to quarter because the mix of business varies depending on which states have heavier concentrations in a given quarter, in terms of the rate change as well as individual large accounts that for one reason may or may not renew.

Our fourth quarter results were in part driven by a few situations where we on the physician larger group business, where we are on the wrong end of a consolidation. One group acquiring the other and ours was the smaller or less influential and we didn't have the opportunity to offer or to get in there and sell the larger group -- the existing group or products. We're certainly going to be back in there next year and the year after to try to do that, but that happens and sometimes we win on those and sometimes we lose. So that will drive new business or retention one way or the other and that's for the most part what happened in the retention numbers for Q4.

Edward Lewis Rand Jr. -- President and Chief Operating Officer and President of Medmarc Insurance Group

Yeah. I think Howard, you were also mentioning to me that fourth quarter 2017, there was a little bit of a spike, so the comparison maybe skewed.

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

Yeah, 92% in Q4 last year was a very good number and we are very happy about it at the time, but it is above the average.

Edward Lewis Rand Jr. -- President and Chief Operating Officer and President of Medmarc Insurance Group

And it is -- also just in -- what Howard said, but as we write larger and larger physician accounts, that retention number will become more volatile.

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

Yes.

Mark Hughes -- SunTrust -- Analyst

Thank you for that. And then one final question, Mike, on the Workers Comp business, the favorable loss cost to really been the story in comp for a while now. The latest trends in frequency and severity, do you have any signals that, that may be changing, is that trend continuing?

Michael Leonard Boguski -- President of Eastern Insurance

Hi, Mark. It's a great question. Our frequency has been -- if you look at it over a long-term basis, it's averaged to be down about 3.8% on average. It's up 3% in '17, it's up about 1% in 2018. But overall, the frequency trends have been -- or starting to stabilize a little bit from the prior years. On the severity side, what we've experienced in our traditional Workers' Comp segment this past year, we saw the trends from the inexperienced workers in a very low unemployment rate economy and that -- on the flip side, we've also seen a slowdown in our SPC business on the severity side, which is a good sign going forward, that's a very economically sensitive business.

So, we think as the economy stabilizes, we get more in a normalized growth rate and unemployment rate that, that will certainly slow down for us on the severity side. I think the other important point there is that a tremendous amount of resources we're putting in to mitigating severity exposures with our risk management investments across our operating territories.

Mark Hughes -- SunTrust -- Analyst

Thank you.

Michael Leonard Boguski -- President of Eastern Insurance

You're welcome.

Operator

The next question will be from Christopher Campbell of KBW. Please go ahead.

Christopher Campbell -- KBW -- Analyst

Yes, hi, good morning.

Frank B. O'Neil -- Senior Vice-President and Chief Communications Officer

Good morning, Chris.

Christopher Campbell -- KBW -- Analyst

Good morning, Frank. I guess my first question is just looking at the physicians pricing within Specialty P&C. It was down about 30 -- or 300 bps sequentially quarter-over-quarter. Anything special happening there in terms of the rate hardening?

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

No, I'd say, it's really just the, again, the mix of accounts, geography and so forth that renewed in the fourth quarter versus what we had in other quarters there in a year and it will vary from quarter to quarter obviously and we are comfortable with the pricing on the renewals and given states are given accounts, we might need more or less and depending on the concentration of those -- the quarterly results will change.

Christopher Campbell -- KBW -- Analyst

Got it, that makes a lot of sense. And then, just another question on the Specialty P&C segment. I understand that you're holding onto the higher loss fix, potential claims cost increases, and it sounds like "for the foreseeable future." So I guess how long should we think about that, just in terms of not 2019, not 2020 and not 2021, I mean -- I guess just given the tale, like how long would it take until you guys felt comfortable about potentially lowering your loss fix and/or releasing some of those as reserves. If you're not -- if you don't see the uptick in higher vertex flow in the year book?

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

Historically, we typically have not changed our initial loss fix in terms of modifying the accident year estimate for typically two years, unless there were something driving it one way or the other. So that's sort of a historical baseline. With the concern that we have about severity, we actually are probably holding it a little longer at this point at least for some of the more recent accident years before we even come to that conclusion. So I'd say a minimum two and it could be longer than that.

Christopher Campbell -- KBW -- Analyst

Got it. So minimum from two from when you started increasing that loss fix, correct?

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

Again, yes, that is our typical view in terms of an accident year. Unless there are something out there that is really dramatically different, we haven't seen dramatically different. I said minimum two from when we started, yes.

Edward Lewis Rand Jr. -- President and Chief Operating Officer and President of Medmarc Insurance Group

Two years is kind of, Chris, just to make sure that you understood two years for each and every accident year. Before we feel like we've got credible data coming through in our paid information. So it's not -- we get two years from kind of when we started and in every accident year we'd be adjusted. We look at the accident years individually and think we need two plus years of data for that accident year.

Christopher Campbell -- KBW -- Analyst

Got it. But right, you say you're in -- OK, so you've raised a lot, so you've boosted a lot of the loss picks in 2018. So if we get to 2020 and you haven't seen these severities materialize, does that -- does that feedback into your accident year 2021 pick, I guess is what I'm trying to trying to understand. Is that because you haven't seen that severity or is you have to kind of factor in -- what you are starting to see in '19?

Edward Lewis Rand Jr. -- President and Chief Operating Officer and President of Medmarc Insurance Group

Yeah, interesting question. Chris, I think going -- kind of perspective it becomes both a blend of our view of what the loss environment is like and then the pricing environment, that will influence. Ultimately, those loss fix we make in any given year perspectively. So certainly, if we began to see in 2020 that the loss environment was improving, that would influence where we would set our 2021 reserves, but also a significant influence of that would be the pricing we're getting in the marketplace.

Christopher Campbell -- KBW -- Analyst

Great. And then just a few on capital management. I know the special dividends a little bit lower. And I guess just in terms of reducing that, does that imply that you're looking at anything near term? And I guess could you just give us some color at a high level, like what would be the type of -- if there was something that you are interested in or inorganically, what kind of premiums, what lines of business Med-Mal or on the Workers Comp side, which states? I guess could you just give us some color on what would be interesting to ProAssurance nowadays?

Edward Lewis Rand Jr. -- President and Chief Operating Officer and President of Medmarc Insurance Group

Sure, so I guess to go to the first part of your question on capital management and we do an evaluation on an annual basis and it's really more regularly with our Board about our capital position and we will take actions as we deem appropriate, and a lot of what factors into that is kind of the prospects we see and then in our short, mid and long-term to deploy capital. And we think with the volatility that we're seeing in the marketplace with the loss severity changes that we anticipate that there will be lots of opportunities to grow our healthcare professional liability business in particular, and so, that is part of what led into the decision around capital.

As we think about the M&A environment, really focus on the areas that we know, so it's really kind of the healthcare professional liability world and the Work Comp world. Things that are still out of our geographic footprint are generally more interesting to us than things that overlap with our geographic footprint. Companies that have specializations and niche players like our podiatric company PICA are interesting to us because they bring something unique to the marketplace. We do not need to do any transactions to expand on our product offerings and really even to expand our geographic reach. But we are -- we don't have the geographic concentrations everywhere. So the transactions we do I think if we do them will be very selective and kind of meet those criteria.

Christopher Campbell -- KBW -- Analyst

Thanks for the extra color and then thanks for all the answers. Good luck next year.

Frank B. O'Neil -- Senior Vice-President and Chief Communications Officer

Thank you.

Operator

The next question will be from Marcos Holanda of Raymond James. Please go ahead.

Marcos Holanda -- Raymond James -- Analyst

Hi, good morning and thanks for taking my questions.

Frank B. O'Neil -- Senior Vice-President and Chief Communications Officer

Thank you, Marcos.

Marcos Holanda -- Raymond James -- Analyst

Yeah, congratulations. Howard, I also wish the best of luck for the new management team. I want to -- I wanted to come back to Med and Mal practice discussion. I was reading an article this morning about a Med-Mal insurer that went under state control earlier this month. And it just got me thinking and I was hoping you guys give us some more color on the landscape that you're seeing. Are -- do you think our facilities and the physicians are tuned to these trends that you guys are seeing or are they now sort of coming after your product, quality coverage, and if you can give us anything on the competition versus the mutuals that would be great?

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

Sure. Yeah, I think the article, you're referring to is the Capson being put into rehabilitation by the Texas Department of Insurance last week, and it's -- it's unfortunate, on the one hand for the policyholders that are involved and it's a -- it's the beginning I think of something that we will see more of in the medical professional liability landscape. If you think about it, I think this is the fourth situation over the past year-and-a-half or so, that one of the smaller relatively younger companies has been in one way or another, put out of business and at the same time, they are small, they are isolated. But I think it's a reflection of what happens in the market when companies are pretty price-oriented in their approach. They tend to not specialize, but look to build the book of business on a very wide ranging geographical basis and the competition really doesn't allow for them to be successful in that regard, if it's just based on price, because there's always somebody is going to push the price down further.

We see a number of the smaller mutual companies that are starting to have pretty high expense ratios. They have plenty of capital obviously, but as the book of business shrinks because of healthcare consolidation and physicians becoming part of larger groups, that some of these small companies can handle or going to work for hospitals and losing the business and fire away through -- to the industry even. Some of these small companies are running high expense ratios and are beginning to run significant combined ratios, as well and are really using the capital what they have to just subsidize the business.

So, I think we'll see more of that in terms of whether physicians and all are tuned to it. I think they will start to be again, there was a lot of attention to this 15 years ago when we had a number of significant insolvencies and physicians losing coverage, guarantee funds being involved and hospitals absorbing claims that should have been paid by those sales physician insurance companies, but it's not at that level. Yes, and depending on the memories, it may take a little while to get there.

Marcos Holanda -- Raymond James -- Analyst

Got it, thanks. Thanks for that color. And then just another one here on Workers' Comp. As it relates to pricing, do you guys think or do you foresee that price -- there could be an inflection point in pricing, even if the economy slows down here in the next couple of years?

Michael Leonard Boguski -- President of Eastern Insurance

The biggest challenge we've seen on the pricing side, is that as a result of the different bureaus and the NCCI looking at frequent -- the frequency based trends that have come down dramatically, loss cost decreases per rates have been pressured. And to some degree in -- on a double-digit basis in some of our core states. So what we tried to do is be more focused on individual account underwriting. Looking at the quality of risk and really pricing it more on a loss pick basis, to put a stable price out there, that's competitive over the long term is a long-term value. So, we're trying to stay away from following the loss costs into the pricing tank and we've been -- we've had a lot of success on that front over from 2011 through the end of 2018, our compound or renewal rate increases have been just about 9%, 8.8%, despite significant loss cost decreases by the rating bureaus. So, we are also hopeful that some of these severity trends will start to convert more into the pricing side as well, but we've been really consistent in our pricing, we protected a high quality book of business and that will continue in 2019.

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

Mike, you might also talk about what drives the cycle as different companies have different views of where loss costs are?

Michael Leonard Boguski -- President of Eastern Insurance

I mean it's -- the competitive pressures are all over the map, frankly. I mean we have some really competitive folks out there, but from a cycle standpoint, when you see -- when you start to see adverse development in comp and those types of issues is when you start to see prices come up and also whether or not the regional and large stock players on the multi-line basis, come in and out the market and that will drive it to some degree.

Marcos Holanda -- Raymond James -- Analyst

Thank you for your answers.

Operator

And Mr. O'Neill, we have no additional questions in the queue. I would like to hand the conference back to you for any final comments.

Frank B. O'Neil -- Senior Vice-President and Chief Communications Officer

That's it, Denise. Thank you very much. We will talk to everybody again in May. Thank you.

Operator

Thank you, sir. Ladies and gentlemen, the conference has concluded. Thank you for attending today's presentation. At this time, you may disconnect your lines.

Duration: 60 minutes

Call participants:

Frank B. O'Neil -- Senior Vice-President and Chief Communications Officer

William Stancil Starnes -- Chairman, Chief Executive Officer and President

Edward Lewis Rand Jr. -- President and Chief Operating Officer and President of Medmarc Insurance Group

Dana Shannon Hendricks -- Chief Financial Officer

Howard Harley Friedman -- President, Healthcare Professional Liability Group; Chief Underwriting Officer and Chief Actuary

Michael Leonard Boguski -- President of Eastern Insurance

Kevin M. Shook -- Executive Vice President-Eastern Alliance Insurance

Amit Kumar -- Buckingham Research -- Analyst

Mark Hughes -- SunTrust -- Analyst

Christopher Campbell -- KBW -- Analyst

Marcos Holanda -- Raymond James -- Analyst

More PRA analysis

Transcript powered by AlphaStreet

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.